COMPOSITION FOR INHIBITING THE ACTIVITY OF INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR SUBTYPE III

摘要

An agent for inhibiting the activity of inositol-1,4,5-triphospate receptor subtype 3 (IP₃R3), containing caffeine and/or its analogs, and/or their pharmaceutically acceptable salts, as an active ingredient, is provided. A composition for preventing and/or treating a disease associated with Ca²⁺ release through IP₃R3, containing the IP₃R3 inhibiting agent, is also provided.